Reuters logo
BRIEF-Karo Pharma says have sold Oasmia shares consisting "down payment" for KB 9520 project
March 3, 2017 / 9:06 AM / 9 months ago

BRIEF-Karo Pharma says have sold Oasmia shares consisting "down payment" for KB 9520 project

March 3 (Reuters) - Karo Pharma AB

* Says board decided on Feb. 2 to sell Oasmia shares consisting “down payment” for KB 9520 project

* Says shares are sold and the board will propose the AGM on May 11 to distribute the value of the shares to its shareholders

* Says chairman Anders Lonner was not part of decision as he was an insider in Oasmia Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below